EUVIMEDEUVIMED entdecken
Crossref

Prognostic factors of male breast cancer: A monocentric experience

Wala Ben Kridis, Mayssa Lajnef, Faida Bouattour, Nabil Toumi, Jamel Daoud, Afef Khanfir

Breast Disease · 2023

DOI: 10.3233/bd-220073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Disease, 2023. Verfasst von Wala Ben Kridis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Habib Bourguiba Hospital, University of Sfax, Sfax, Tunisia. Hauptthemen laut MEDLINE: Breast Neoplasms, Male, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Male breast cancer (MBC) is a rare malignancy presenting only 1% of all breast cancer. The purpose of this study was to analyze clinical and pathological prognostic factors of MBC. METHODS: This is a retrospective study including 32 men diagnosed and treated for a primary breast cancer at the department of medical oncology in Sfax between 2005 and 2020. RESULTS: The incidence of MBC was 1.3%. The median age of our patients was 55 years (range: 29–85 years). The average tumor size of 3.9 cm. Lymph nodes involvement was present in 18 cases (56.2%) with capsular rupture in 52% cases. Tumor was grade II in 71.8 % of cases. The expression of hormonal receptors was founded in 100% of cases. Two patients had an overexpression of HER2 (6.2%). There was no case of triple negative MBC. The OS at 5 and 10 years was 67.8% and 30.8% respectively. Prognostic factors were T4 (p = 0.015), involved nodes (p = 0.035), M+ (p = 0.01), SBR III (p = 0.0001) and HER2+++ (p = 0.001). CONCLUSION: Contrary to breast cancer in women, our study showed that Tunisian MBC have positive hormone receptors in all cases. Although the overexpression of HER2 was low (8.33%) and there was no case of triple negative MBC, the prognosis was poor because of T4 stage, involved nodes, SBR III and distant metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast Neoplasms, MaleTriple Negative Breast NeoplasmsHumansFemaleMaleAdultMiddle AgedAgedAged, 80 and overPrognosisRetrospective Studies

Stichwörter der Autor:innen

Male breast cancerprognosissurvival

Autor:innen und Institutionen

  • Department of Medical Oncology, Habib Bourguiba Hospital, University of Sfax, Sfax, Tunisia.
  • Department of Radiotherapy, Habib Bourguiba Hospital, University of Sfax, Sfax, Tunisia.

Zitieren

APA

Ben Kridis, W., Lajnef, M., Bouattour, F., Toumi, N., Daoud, J., & Khanfir, A. (2023). Prognostic factors of male breast cancer: A monocentric experience. Breast Disease. https://doi.org/10.3233/bd-220073

Vancouver

Ben Kridis W, Lajnef M, Bouattour F, Toumi N, Daoud J, Khanfir A. Prognostic factors of male breast cancer: A monocentric experience. Breast Disease. 2023. doi:10.3233/bd-220073

BibTeX
@article{BenKridis2023,
  author = {Ben Kridis, Wala and Lajnef, Mayssa and Bouattour, Faida and Toumi, Nabil and Daoud, Jamel and Khanfir, Afef},
  title = {Prognostic factors of male breast cancer: A monocentric experience},
  journal = {Breast Disease},
  year = {2023},
  doi = {10.3233/bd-220073}
}
Kostenlos starten →